Benzinga | Feb 25, 2021 04:03PM EST

Evolent Health Q4 EPS $(0.01) Beats $(0.05) Estimate, Sales $271.90M Beat $261.55M Estimate

Evolent Health (NYSE:EVH) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.05) by 80 percent. This is a 85.71 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $271.90 million which beat the analyst consensus estimate of $261.55 million by 3.96 percent. This is a 14.48 percent increase over sales of $237.51 million the same period last year.